BBNX Beta Bionics, Inc. - 8-K

Item 5.07 Submission of Matters to a Vote of Security
Holders.

On May 21, 2026,
Beta Bionics, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). The Company’s
definitive proxy statement for the Annual Meeting was filed with the U.S. Securities and Exchange Commission on April 10, 2026 and describes
in detail the two proposed voting matters (the “Proposals”) submitted to the Company’s stockholders at the Annual Meeting.
The final results for the votes cast with respect to each Proposal are set forth below.

As of March 23, 2026, the record date for the Annual
Meeting, there were 44,561,695 outstanding shares of the Company’s common stock. At the Annual Meeting, a quorum of 36,061,048 shares
of the Company’s common stock were represented in person or by proxy.

Proposal 1. Election of Directors

The Company’s stockholders elected two Class I
directors, Sean D. Carney and Christy Jones, to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly
elected and qualified, or until their earlier death, resignation or removal, by the following vote:

Name
of Director

Votes
For

Votes
Withheld

Broker
Non-Votes

Sean D. Carney

30,659,060

608,992

4,792,996

Christy Jones

25,865,542

5,402,510

4,792,996

Proposal 2. Ratification of Appointment of Independent Registered Public Accounting Firm

The Company’s stockholders ratified the appointment by the Audit Committee
of the Company’s Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm
for the fiscal year ending December 31, 2026, by the following vote:

Votes
For

Votes
Against

Abstentions

36,011,432

41,527

8,089

No other items were presented for stockholder approval at the Annual
Meeting.